These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24624034)

  • 1. Prophylaxis with levofloxacin: impact on bacterial susceptibility and epidemiology in a hematopoietic stem cell transplant unit.
    Lopes LA; Veroneze I; Burgardt CI; Niebel Stier CJ
    Rev Bras Hematol Hemoter; 2014; 36(1):35-42. PubMed ID: 24624034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of bacterial infections in allogeneic hematopoietic stem cell transplant recipients who received prophylactic levofloxacin with either penicillin or doxycycline.
    Therriault BL; Wilson JW; Barreto JN; Estes LL
    Mayo Clin Proc; 2010 Aug; 85(8):711-8. PubMed ID: 20675508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
    Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of Levofloxacin Prophylaxis Timing in Autologous and Allogeneic Stem Cell Transplantation: A Retrospective Cohort Study.
    Özkan SG; Safaei S; Kimiaei A; Çınar Y; Sönmezoğlu M; Özkan HA
    Cureus; 2024 Apr; 16(4):e57598. PubMed ID: 38707020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
    Signorelli J; Zimmer A; Liewer S; Shostrom VK; Freifeld A
    Transpl Infect Dis; 2020 Apr; 22(2):e13225. PubMed ID: 31785022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.
    Ziegler M; Landsburg D; Pegues D; Bilker W; Gilmar C; Kucharczuk C; Gorman T; Bink K; Moore A; Fitzpatrick R; Stadtmauer EA; Mangan P; Kraus K; Han JH
    Biol Blood Marrow Transplant; 2019 May; 25(5):1004-1010. PubMed ID: 30481595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.
    Drayson MT; Bowcock S; Planche T; Iqbal G; Pratt G; Yong K; Wood J; Raynes K; Higgins H; Dawkins B; Meads D; Hulme CT; Whittaker AC; Hawkey P; Low E; Dunn JA
    Health Technol Assess; 2019 Nov; 23(62):1-94. PubMed ID: 31690402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
    Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution.
    Cattaneo C; Quaresmini G; Casari S; Capucci MA; Micheletti M; Borlenghi E; Signorini L; Re A; Carosi G; Rossi G
    J Antimicrob Chemother; 2008 Mar; 61(3):721-8. PubMed ID: 18218645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients.
    Frère P; Hermanne JP; Debouge MH; Fillet G; Beguin Y
    Bone Marrow Transplant; 2002 Apr; 29(7):589-94. PubMed ID: 11979308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study on the usefulness of antibacterial prophylaxis with levofloxacin in patients submitted to hematopoietic stem cell transplantation].
    Fernandez Sojo J; Batlle Massana M; Morgades M; Vives Polo S; Quesada MD; Ribera Santasusana JM
    Med Clin (Barc); 2016 Jan; 146(1):16-9. PubMed ID: 26343154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levofloxacin versus Cefpodoxime for Antibacterial Prophylaxis in Allogeneic Stem Cell Transplantation.
    Doan VP; Yeh JC; Gulbis AM; Aitken SL; Ariza-Heredia E; Ahmed S
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1637-1641. PubMed ID: 31002991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin vs. levofloxacin for prophylaxis in recipients of hematopoietic stem cell transplantation.
    Rambaran KA; Seifert CF
    J Oncol Pharm Pract; 2019 Jun; 25(4):884-890. PubMed ID: 30041584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
    Cumpston A; Craig M; Hamadani M; Abraham J; Hobbs GR; Sarwari AR
    Transpl Infect Dis; 2013 Apr; 15(2):142-9. PubMed ID: 23279656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem-cell transplantation.
    Copeland V; McLaughlin M; Trifilio S
    Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29080369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of fluoroquinolone-resistant Escherichia coli in the fecal flora of hematological patients with neutropenia and levofloxacin prophylaxis.
    Chong Y; Shimoda S; Yakushiji H; Ito Y; Aoki T; Miyamoto T; Kamimura T; Shimono N; Akashi K
    PLoS One; 2014; 9(1):e85210. PubMed ID: 24465506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of gram-negative bacteremia during febrile neutropenia among allogeneic hematopoietic stem cell transplant recipients on levofloxacin prophylaxis.
    Ogura S; Kimura M; Takagi S; Mitsuki T; Yuasa M; Kageyama K; Kaji D; Nishida A; Taya Y; Ishiwata K; Yamamoto H; Asano-Mori Y; Yamamoto G; Uchida N; Wake A; Taniguchi S; Araoka H
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):941-948. PubMed ID: 33185742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
    Reuter S; Kern WV; Sigge A; Döhner H; Marre R; Kern P; von Baum H
    Clin Infect Dis; 2005 Apr; 40(8):1087-93. PubMed ID: 15791505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
    Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
    BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levofloxacin for Antibacterial Prophylaxis in Pediatric Patients With Acute Myeloid Leukemia or Undergoing Hematopoietic Stem Cell Transplantation.
    Patel B; Noda A; Godbout E; Stevens M; Noda C
    J Pediatr Pharmacol Ther; 2020; 25(7):629-635. PubMed ID: 33041718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.